0001059784-12-000002.txt : 20120905 0001059784-12-000002.hdr.sgml : 20120905 20120905111921 ACCESSION NUMBER: 0001059784-12-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20120905 DATE AS OF CHANGE: 20120905 EFFECTIVENESS DATE: 20120905 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GENEREX BIOTECHNOLOGY CORP CENTRAL INDEX KEY: 0001059784 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 820490211 STATE OF INCORPORATION: DE FISCAL YEAR END: 0731 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-183643 FILM NUMBER: 121072835 BUSINESS ADDRESS: STREET 1: 33 HARBOUR SQ STREET 2: STE 202 CITY: TORONTO ONTARIO CANADA STATE: A1 ZIP: M5J 2G2 BUSINESS PHONE: 4163642551 MAIL ADDRESS: STREET 1: 33 HARBOUR SQ STREET 2: STE 202 CITY: TORONTO ONTARIO CA STATE: A1 ZIP: M5J 2G2 D 1 primary_doc.xml X0706 D LIVE 0001059784 GENEREX BIOTECHNOLOGY CORP 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANADA A1 BRITISH COLUMBIA, CANADA M5J 2G2 4163642551 DELAWARE None None Corporation true Mark A. Fletcher 33 HARBOUR SQUARE SUITE 202 TORONTO A6 ONTARIO, CANADA M5J 2G2 Executive Officer Director Nola E. Masterson 33 HARBOUR SQUARE SUITE 202 TORONTO A6 ONTARIO, CANADA M5J 2G2 Director Eric von Hofe, Ph.D. 33 HARBOUR SQUARE SUITE 202 TORONTO A6 ONTARIO, CANADA M5J 2G2 Director James H. Anderson, Jr., M.D. 33 HARBOUR SQUARE SUITE 202 TORONTO A6 ONTARIO, CANADA M5J 2G2 Director Stephen Fellows 33 HARBOUR SQUARE SUITE 202 TORONTO A6 ONTARIO, CANADA M5J 2G2 Executive Officer David Brusegard, Ph.D. 33 HARBOUR SQUARE SUITE 202 TORONTO A6 ONTARIO, CANADA M5J 2G2 Executive Officer John P. Barratt 33 HARBOUR SQUARE SUITE 202 TORONTO A6 ONTARIO, CANADA M5J 2G2 Director Brian T. McGee 33 HARBOUR SQUARE TORONTO A6 ONTARIO, CANADA M5J 2G2 Director Pharmaceuticals $1 - $1,000,000 06 false 2012-08-10 false true true true false 50000 Seahawk Capital Partners, Inc. None None None 147 MAIN STREET, SECOND FLOOR COLD SPRING HARBOR NY NEW YORK 11724 NJ NEW JERSEY NY NEW YORK false 750000 750000 0 false 7 0 60000 0 false GENEREX BIOTECHNOLOGY CORP Mark A. Fletcher Mark A. Fletcher President 2012-09-05